-
1
-
2
-
3
Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)
Veröffentlicht in The American heart journal
VolltextArtikel -
4
-
5
-
6
-
7
-
8
-
9
-
10
Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure
Veröffentlicht in The New England journal of medicine
VolltextArtikel -
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20